Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Nominations for Techweek 100 list of premier KC innovators close Sept. 9
It’s not a ranking. Techweek 100 celebrates the whole spectrum of individuals and organizations who are impacting the business and technology landscape on a significant scale in cities like Kansas City, organizers said. Nominations close Sunday, Sept. 9. “Honorees include fast-growing technology companies, prominent sector investors, key contributing enablers of the digital ecosystem, those at…
Lenexa teen IDs winning medical solution with Parkinson’s detection tech FacePrint
Stanford University will have to wait. Eighteen-year-old Erin Smith is taking her medical technology venture, FacePrint, on the road. The Johnson County teen has been selected to join two prestigious fellowships to further develop FacePrint, which is a diagnostic and monitoring Tool for Parkinson’s Disease. She’s been tapped for $25,000 from the Davidson Institute for…
Velocity Lee’s Summit gets first big boost from city with $145K innovation investment
A $145,000 allocation for Velocity Lee’s Summit represents the first step in the City of Lee’s Summit getting serious about investing in innovation, said Grant Gooding. “There is a lot of talent in Lee’s Summit and we wanted to give entrepreneurs a place and an ecosystem to foster the development of their businesses,” said Gooding,…
Pure Pitch Rally returning to Techweek with land sharks hungry to invest more than $80K
A frenzy of land sharks ready to bite on startups’ best ideas is gathering at The American restaurant during Techweek to award up to $80,000 in cash and $500,000 in Amazon AWS Activate credits. The one-of-a-kind Pure Pitch Rally event — set for 4 p.m. to 6 p.m. Oct 10 — plays off the hit…